Palvella Therapeutics PVLA Declines 445 Amid Market Weakness 20260515 Trump to Decide on Sanctions Relief for Chinese Oil Companies Purchasing Iranian Oil Global Markets Brace as World Leaders Await TrumpXi Summit Outcome TikToks 30 Creator Correspondents Signal FIFAs Strategic Shift in World Cup Media Rights EU Parliament Approves Implementation of US Tariff Deal as Transatlantic Trade Tensions Persist Major Tech and Chip Companies Invest 125 Million in UCLA Semiconductor Research Hub Amazon Allegedly Made Millions from NowIllegal Policy Singapore Bankruptcy Rise Overspending and Business Failures as Key Drivers Perpetua Resources Secures 29 Billion US ExportImport Bank Loan for Idaho Gold and Antimony Project Nomura RBIs Surprise Rate Cut May Have Diluted Its Policy Framework TALK Q1 2026 Earnings Significant EPS Miss Amid Operational Uncertainty CBSH Q1 2026 Earnings EPS Surpasses Estimates by 71 Amid Solid Operating Performance Century Communities Q1 2026 Earnings EPS Surges 68 Above Estimates Shares Edge Lower OnKure Therapeutics Inc OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline Village Farms International VFF Q1 2026 Earnings EPS Misses Estimates Slightly Amid Undisclosed Revenue HOMB Q1 2026 Earnings EPS Slightly Misses Estimate Shares Modestly Higher Bain Capital Specialty Finance BCSF Shares Slip 08 Amid NearTerm Resistance Test LINKBANCORP LNKB Holds Steady Near 869 as Traders Weigh Support and Resistance Levels Inspira Technologies IINN Holds Steady Near Key Resistance as Traders Await Catalyst AN2 Therapeutics ANTX Slides 27 as Shares Test Support Near 427 Nabors Industries NBR Holds Near Support as Energy Sector Faces Uncertainty US Prioritizes AI Integration in Asia Following TrumpXi Summit Official Says ZNTL Q1 2026 Earnings PreRevenue Biotech Posts WiderthanExpected Net Loss Adagene ADAG Slips 106 as Stock Tests Key Support Near 356 CLPT Q1 2026 Earnings EPS Misses Estimates as ClearPoint Neuro Continues Strategic Investments Clear Secure Inc YOU Q1 2026 Earnings EPS Beats Estimates by 12 Despite Stock Pullback NN Q1 2026 Earnings Surpasses EPS Estimates Amid Revenue Disclosures TSHA Q1 2026 Earnings EPS Misses Estimates as Company Advances Gene Therapy Pipeline ACRS Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues IIIN Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick OMC Q1 2026 Earnings EPS Beats Estimates by 179